SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Feb-24 4:25 PM View: | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 5,362 | $737.26 | $3,953,190.00 | 13% 39.76K to 45.12K | |
02-Feb-24 4:26 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 1,844 | $645.61 | $1,190,500.00 | (4%) 41.6K to 39.76K | |
02-Feb-24 4:26 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 4,124 | -- | -- | 11% 37.48K to 41.6K | |
02-Jun-23 4:29 PM View: | Eli Lilly & Co. (LLY) | 01-Jun-23 | Private Sale (Planned) | 6,000 | $429.46 | $2,576,760.00 | (14%) 43.47K to 37.47K | |
14-Feb-23 10:00 PM View: | Eli Lilly & Co. (LLY) | 10-Feb-23 | Grant | 7,886 | $345.12 | $2,721,620.00 | 22% 35.52K to 43.41K | |
03-Feb-23 4:48 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-23 | Payment of Exercise | 2,997 | $344.15 | $1,031,420.00 | (8%) 38.52K to 35.52K | |
03-Feb-23 4:48 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-23 | Option Exercise | 6,690 | -- | -- | 21% 31.83K to 38.52K | |
17-Mar-22 4:12 PM View: | Eli Lilly & Co. (LLY) | 17-Mar-22 | Private Sale (Planned) | 673 | $277.20 | $186,556.00 | (2%) 32.44K to 31.77K | |
03-Mar-22 6:30 PM View: | Eli Lilly & Co. (LLY) | 01-Mar-22 | Market Sale (Planned) | 675 | $247.56 | $167,103.00 | (2%) 33.12K to 32.44K | (5%) |
11-Feb-22 6:16 PM View: | Eli Lilly & Co. (LLY) | 09-Feb-22 | Grant | 2,036 | $243.27 | $495,298.00 | 7% 31.06K to 33.1K | 7% |
10-Feb-21 8:32 PM View: | Eli Lilly & Co. (LLY) | 08-Feb-21 | Grant | 5,595 | $205.77 | $1,151,280.00 | 22% 25.51K to 31.1K | (2%) |
13-Feb-20 5:39 PM View: | Eli Lilly & Co. (LLY) | 11-Feb-20 | Grant | 5,702 | $144.25 | $822,514.00 | 29% 19.51K to 25.21K | 13% |